Sameer H. Issaq

524 total citations
11 papers, 299 citations indexed

About

Sameer H. Issaq is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sameer H. Issaq has authored 11 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Sameer H. Issaq's work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer-related Molecular Pathways (4 papers) and Sarcoma Diagnosis and Treatment (2 papers). Sameer H. Issaq is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Cancer-related Molecular Pathways (4 papers) and Sarcoma Diagnosis and Treatment (2 papers). Sameer H. Issaq collaborates with scholars based in United States and Malaysia. Sameer H. Issaq's co-authors include Arnulfo Mendoza, Lee J. Helman, Amy K. LeBlanc, Anne Monks, Ling Ren, Beverly A. Teicher, Stephen D. Fox, Christine M. Heske, Kian‐Huat Lim and Christopher M. Counter and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncotarget.

In The Last Decade

Sameer H. Issaq

10 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sameer H. Issaq United States	9	195	152	78	48	23	11	299
Sarah Courtois France	11	235 1.2×	133 0.9×	121 1.6×	47 1.0×	20 0.9×	16	358
Christoph Wohlkoenig Austria	7	281 1.4×	189 1.2×	80 1.0×	65 1.4×	19 0.8×	9	413
Sanika Khare United States	6	171 0.9×	218 1.4×	58 0.7×	55 1.1×	10 0.4×	7	368
Katja Helenius Finland	5	276 1.4×	89 0.6×	119 1.5×	48 1.0×	23 1.0×	6	383
Lin‐wen Wu China	12	225 1.2×	82 0.5×	88 1.1×	69 1.4×	22 1.0×	18	381
Valérie Vial France	8	205 1.1×	147 1.0×	68 0.9×	46 1.0×	19 0.8×	14	332
Peter J. Mullen Canada	3	228 1.2×	88 0.6×	37 0.5×	20 0.4×	16 0.7×	4	290
Rahul Sreekumar United Kingdom	7	199 1.0×	123 0.8×	110 1.4×	33 0.7×	15 0.7×	12	317
Xingling Zheng China	9	322 1.7×	95 0.6×	89 1.1×	38 0.8×	28 1.2×	12	431

Countries citing papers authored by Sameer H. Issaq

Since Specialization

Citations

This map shows the geographic impact of Sameer H. Issaq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameer H. Issaq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameer H. Issaq more than expected).

Fields of papers citing papers by Sameer H. Issaq

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sameer H. Issaq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameer H. Issaq. The network helps show where Sameer H. Issaq may publish in the future.

Co-authorship network of co-authors of Sameer H. Issaq

This figure shows the co-authorship network connecting the top 25 collaborators of Sameer H. Issaq. A scholar is included among the top collaborators of Sameer H. Issaq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sameer H. Issaq. Sameer H. Issaq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Issaq, Sameer H., Arnulfo Mendoza, Damien Duveau, et al.. (2020). EWS-FLI1–regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor Growth. Molecular Cancer Therapeutics. 19(7). 1520–1529. 25 indexed citations

Ren, Ling, Victor Ruiz‐Rodado, Tyrone Dowdy, et al.. (2020). Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma. SHILAP Revista de lepidopterología. 8(1). 4–4. 79 indexed citations

Yeung, Choh, Sameer H. Issaq, Yiping Zhang, et al.. (2020). Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) with OT-82 induces DNA damage, cell death, and suppression of tumor growth in preclinical models of Ewing sarcoma. Oncogenesis. 9(9). 80–80. 22 indexed citations

Issaq, Sameer H., et al.. (2020). The In Vivo Role of the RP-Mdm2-p53 Pathway in Signaling Oncogenic Stress Induced by pRb Inactivation and Ras Overexpression. UNC Libraries.

Issaq, Sameer H., Arnulfo Mendoza, Stephen D. Fox, & Lee J. Helman. (2019). Glutamine synthetase is necessary for sarcoma adaptation to glutamine deprivation and tumor growth. Oncogenesis. 8(3). 20–20. 43 indexed citations

Issaq, Sameer H. & Christine M. Heske. (2019). Targeting metabolic dependencies in pediatric cancer. Current Opinion in Pediatrics. 32(1). 26–34. 11 indexed citations

Ren, Ling, Ellen S. Hong, Arnulfo Mendoza, et al.. (2017). Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis. Oncotarget. 8(24). 38541–38553. 38 indexed citations

Issaq, Sameer H., Beverly A. Teicher, & Anne Monks. (2014). Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors. Cell Cycle. 13(7). 1152–1161. 35 indexed citations

Issaq, Sameer H., et al.. (2011). The In Vivo Role of the RP-Mdm2-p53 Pathway in Signaling Oncogenic Stress Induced by pRb Inactivation and Ras Overexpression. PLoS ONE. 6(6). e21625–e21625. 16 indexed citations

10.

Issaq, Sameer H., Kian‐Huat Lim, & Christopher M. Counter. (2010). Sec5 and Exo84 Foster Oncogenic Ras-Mediated Tumorigenesis. Molecular Cancer Research. 8(2). 223–231. 28 indexed citations

11.

Issaq, Sameer H., et al.. (2001). THE SEPARATION OF A PENICILLIUM FUNGAL EXTRACT BY THIN LAYER CHROMATOGRAPHY AND HPLC: A COMPARATIVE STUDY. Journal of Liquid Chromatography & Related Technologies. 24(5). 625–633. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact